CALL/MERCK & CO./140/0.1/17.01.25 Share Price

Warrant

DE000GZ9BGC4

Real-time BOERSE MUENCHEN 19:25:32 27/06/2024 BST
0.338 EUR -35.25% Intraday chart for CALL/MERCK & CO./140/0.1/17.01.25
Current month+64.67%
1 month+21.40%
Date Price Change
27/06/24 0.338 -35.25%
26/06/24 0.522 -5.26%
25/06/24 0.551 +6.99%
24/06/24 0.515 +20.33%
21/06/24 0.428 -0.93%

Real-time BOERSE MUENCHEN

Last update June 27, 2024 at 07:25 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Goldman Sachs
WKN GZ9BGC
ISINDE000GZ9BGC4
Date issued 27/02/2023
Strike 140 $
Maturity 17/01/2025 (204 Days)
Parity 10 : 1
Emission price 0.45
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.703
Lowest since issue 0.058
Spread 0.01
Spread %2.63%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.5 USD
Average target price
142.7 USD
Spread / Average Target
+8.50%
Consensus